OR-GUROBI-OPTIMIZATION
2.6.2022 23:28:10 CEST | Business Wire | Press release
Gurobi Optimization, LLC , creator of the world’s fastest mathematical optimization solver, announced the launch of their new educational game that aims to show players the power of optimization. The “Burrito Optimization Game” is a free, web-based app designed for data science and operations research students, as well as anyone who stands to benefit from mathematical optimization. In addition to demonstrating the value of optimization, the game also proves its difficulty, as well as the importance of algorithms and solvers in finding an optimal solution.
Gurobi created the Burrito Optimization Game in collaboration with Dr. Larry Snyder of Lehigh University, who explains that at the time he and Gurobi started work on the project, there were several other projects in the data science community that used the premise of locating a hypothetical new restaurant. The projects scored possible locations based on demographics, demand, and other data science factors.
“As optimizers, we know it can be easy to pick the single best location once you have a score, but if you need to pick five, ten, or fifty locations, especially when there are thousands to choose from, that becomes a very different kind of problem,” says Dr. Snyder. “So we decided to use this as a way to introduce the optimization story, hoping that the idea of first coming up with a score for each location and then putting that into an optimization context would resonate, even for data scientists who hadn’t seen the restaurant examples.”
Gurobi’s game is based on a classic facility location problem and allows players to choose the best locations for a “Guroble” food truck, with the goal of maximizing their total profit. For each level, players are presented with a new story, with added complexity, and a set of data to help them make decisions. The data provided typically includes the cost of each truck, the price of ingredients, and the total sales revenue for each burrito sold, as well as scenarios that will impact decision-making—such as disruptions in the burrito ingredient supply chain, or weather conditions that impact a customer’s willingness to travel.
Players can drag and drop their Guroble trucks around an illustrated map, where they can see how many customers are in each building. The closer the truck is to a building, the more customers from that building will be willing to walk to the truck to buy a burrito. Players can see how their profits adjust when they drag and drop the truck to a different location, highlighting the importance of trade-offs in complex decision-making.
Once a player is satisfied with their placement of the trucks, Gurobi will solve the problem and find the optimal solution within a fraction of a second. Players can then see how far they were from the optimal solution in terms of total profit.
The game also provides tips along the way to further the learning experience once players submit their solution. For example, players might be notified that a certain part of the city is underserved, or they’ll see a hint that their solution has the optimal number of trucks, but in the wrong locations.
In subsequent rounds, the game introduces uncertainties for an added challenge. Players need to build their solutions based off of forecasts rather than actual demand in this game—a concept that’s very familiar for data science students. For example, there might be 25 potential customers forecast in a building, but the actual amount could be off by up to five customers. Error bars indicate how far in either direction the actual demands might be.
“What we’re hoping to convey is that if you were to try optimization by trial and error, it’s not only tedious and time-consuming, but it’s also hard to make good decisions,” explains Dr. Snyder. “We also wanted to make clear that although optimization is hard, it’s a mature scientific field with robust commercial and open-source software that can solve these problems for us.”
“We launched this a little while ago, and the early feedback has been extremely positive,” explained Dr. Edward Rothberg, Chief Executive Officer and Co-founder of Gurobi Optimization. “One common response from optimization professionals is excitement about the prospect of having a simple, entertaining way to show the people they work with the sorts of problems optimization can solve and the power that it brings.”
The Burrito Optimization Game is available on Gurobi’s website , accompanied by a series of resources that highlight intended educational takeaways and explain how instructors can teach the game in a classroom setting or how players can use the game on their own.
About Gurobi Optimization
Gurobi produces the world’s fastest and most powerful mathematical optimization solver—the Gurobi Optimizer—which is used by leading global companies across more than 40 different industries to rapidly solve their complex, real-world problems and make automated decisions that optimize their efficiency and profitability. As the market leader in mathematical optimization software, we aim to deliver not only the best solver, but also the best support—so that companies can fully leverage the power of mathematical optimization (on its own or in combination with other AI techniques such as machine learning) to drive optimal business decisions and outcomes.
Founded in 2008, Gurobi has operations across the Americas, Europe, and Asia and has more than 2,500 customers globally including SAP, Air France, Uber, and the National Football League (NFL). For more information, please visit https://www.gurobi.com/ or call +1 713 871 9341.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005982/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
